|
FDA Names Permanent Director of Surveillance Office
The FDA has tapped Gerald Dal Pan, the acting director of the newly reorganized Office of Surveillance and Epidemiology (OSE), to head up the office permanently, agency officials say.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives